Onderneming BioForce Nanosciences Holdings, Inc. Other OTC
Aandelen
BFNH
US09064C2061
Overige speciaalzaken
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gagnon
CEO | Chief Executive Officer | 62 | 30-11-21 |
John LaViolette
CEO | Chief Executive Officer | 62 | 30-11-21 |
Sasha Shapiro
PSD | President | 61 | 30-11-21 |
Richard Kaiser
DFI | Director of Finance/CFO | 59 | 01-07-13 |
Merle Ferguson
CHM | Chairman | 76 | 08-07-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Merle Ferguson
CHM | Chairman | 76 | 08-07-13 |
Richard Kaiser
DFI | Director of Finance/CFO | 59 | 01-07-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 29 271 755 | 4 213 755 ( 14,40 %) | 0 | 14,40 % |
Bedrijfsgegevens
BioForce Nanosciences Holdings, Inc.
2020 General Booth Boulevard Suite 230
23454, Virginia Beach
+
http://www.bioforcenano.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 843 mln. | |
+10,24% | 743 mln. | |
+30,88% | 477 mln. | |
+35,91% | 262 mln. | |
0,00% | 130 mln. | |
+134,78% | 63,1 mln. |